HomeNews Open Dialogue in CML Care: Setting Expectations, Managing Aspect Results, and Optimizing Affected person High quality of Life News August 14, 2024 121 0 Purposeful Precision Drugs: The New Precision Oncology? August 6, 2026 The Story of Immune Checkpoint Inhibitors and Immunotherapy July 21, 2026 Reflections on Progress at ASCO 2026 June 23, 2026 NCI’s Message and High Priorities June 16, 2026 NCI’s Message and High Priorities May 4, 2026 A panel of consultants on power myeloid leukemia focus on frequent affected person issues, adversarial impact concerns, and greatest practices for setting clear expectations. Share FacebookTwitterPinterestWhatsApp Previous articleMuch less-Intense Chemotherapy Could Be Preferrable in Older Sufferers with AMLNext articleAC699 Quick-Tracked for ESR1-Mutant Breast Most cancers Hot Topics Purposeful Precision Drugs: The New Precision Oncology? The Story of Immune Checkpoint Inhibitors and Immunotherapy Reflections on Progress at ASCO 2026 Load more Related Articles Editor - August 6, 2026Purposeful Precision Drugs: The New Precision Oncology? Editor - July 21, 2026The Story of Immune Checkpoint Inhibitors and Immunotherapy Editor - June 23, 2026Reflections on Progress at ASCO 2026 Load more
